Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CCL23 Biologics Sequence Review Report 2026: C-C motif chemokine 23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL23 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
CCL15 Biologics Sequence Review Report 2026: C-C motif chemokine 15 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TGFBRAP1 Biologics Sequence Review Report 2026: Transforming growth factor-beta receptor-associated protein 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TGFBRAP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
TGFBR3 Biologics Sequence Review Report 2026: Transforming growth factor beta receptor type 3 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TGFBR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
NTRK3 Biologics Sequence Review Report 2026: NT-3 growth factor receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of NTRK3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
NTRK2 Biologics Sequence Review Report 2026: BDNF/NT-3 growth factors receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of NTRK2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
NTRK1 Biologics Sequence Review Report 2026: High affinity nerve growth factor receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of NTRK1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
LILRB1 Biologics Sequence Review Report 2026: Leukocyte immunoglobulin-like receptor subfamily B member 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LILRB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
ILDR2 Biologics Sequence Review Report 2026: Immunoglobulin-like domain-containing receptor 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of ILDR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
IL27RA Biologics Sequence Review Report 2026: Interleukin-27 receptor subunit alpha Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL27RA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL1RAPL2 Biologics Sequence Review Report 2026: X-linked interleukin-1 receptor accessory protein-like 2 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL1RAPL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Latest Hotspot
8 min read
IL1RAPL1 Biologics Sequence Review Report 2026: Interleukin-1 receptor accessory protein-like 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of IL1RAPL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.